Adoptively transferred CD4+ lymphocytes from CD8 -/-mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4114-4119

  Dalloul, Ali H ^a,b   Chmouzis, Erica ^a   Ngo, Karen ^a,c   Fung Leung, Wai Ping ^a,c  

^a R W Johnson Pharmaceutical Res I   (Canada)

^b INSERM   (France)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD8; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOTHERAPY, ADOPTIVE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MODELS, BIOLOGICAL; SKIN TRANSPLANTATION;

EID: 0029888609     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hall, B. M. 1991. Cells mediating allograft rejection. Transplantation 51:1141.
2. 2 microglobulin deficient mice. J. Exp. Med. 17:885.
3. Chicz, R. M., R. G. Urban, W. S. Lane, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
4. Chicz, R. M., G. Urban, J. C. Gorga, A. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
5. Sayegh, M., B. Watschinger, and C. B. Carpenter. 1994. Mechanisms of T cell recognition of alloantigen. Transplantation 57:1295.
6. Heath, W. R., and L. A. Sherman. 1990. Cell-type specific recognition of allogeneic cells by alloreactive cytotoxic T cells: consequence of peptide dependent allorecognition. Eur. J. Immunol. 21:153.
7. Benichou, G., P. A. Takizawa, C. A. Olson, M. McMillan, and E. E. Sercarz. 1992. Donor MHC peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175:305.
8. Dalchau, R., J. Fangmann, and J. W. Fabre. 1992. Allorecognition of denatured chains of class I and class II MHC complex molecules: evidence for an important role for indirect allorecognition in transplantation. J. Exp. Med. 173:1463.
9. Auchinloss, H., Jr., R. Lee, S. Shea, J. S. Markowicz, M. J. Grusby, and L. H. Glimcher. 1993. The role of "indirect recognition" in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90:3373.
10. Lee, R. S., M. J. Grusby, L. H. Glimcher, H. J. Winn, and H. Auchinloss, Jr. 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179:865.
11. + T cells in vivo. J. Exp. Med. 173:1463.
12. Fung-Leung, W.-P., M. W. Schilham, A. Rahemtulla, T. M. Kundig, M. Vollenveider, J. Potter, W. van Evijk, and T. W. Mak. 1991. CD8 is needed for the development of cytotoxic T cells but not helper T cells. Cell 65:443.
13. Dalloul, A. H., K. N'Go, and W.-P. Fung-Leung. 1996. CD4 negative cytotoxic T cells with a TCR/αβ intermediate expression in CD8 deficient mice. Eur. J. Immunol. 26:213.
14. Schilham, M. W., W.-P. Fung-Leung, A. Rahemtulla, T. Kundig, L. Zhang, T. Potter, R. G. Miller, H. Hengartner, and T. W. Mak. 1993. Alloreactive cytotoxic T cells can develop in mice lacking both CD4 and CD8. Eur. J. Immunol. 23:1299.
15. + cells. Science 248:1227.
16. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
17. Pope, B. L., E. Chourmouzis, L. Victorino, J. P. McIntyre, R. J. Capetola, and C. Y. Lau. 1993. Loxiribine activates natural killer cells and primes cytolytic precursor cells for activation by IL-2. J. Immunol. 151:3007.
18. McIntyre, J. P., D. W. Hoskin, and B. L. Pope. 1990. Splenic natural cytotoxicity is enhanced during growth of fibrosarcoma. Immunobiology 180:243.
19. O'Connell, P. J., A. Pacheco-Silva, P. W. Nickerson, R. A. Muggia, M. Bastos, V. R. Kelley, and T. B. Strom. 1993. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J. Immunol. 150:1093.
20. Takeuchi, T., R. P. Lowry, and B. Konieczny. 1992. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53:1281.
21. Dallman, M. J., C. P. Larsen, and P. J. Morris. 1991. Cytokine gene transcription in vascularized organ grafts: analysis using semiquantitative PCR. J. Exp. Med. 174:493.
22. + cells mediate skin rejection. J. Exp. Med. 153:1044.
23. LeFrancois, L., and M. J. Bevan. 1984. A re-examination of the role of Lyt-2,3-positive T cells in murine skin graft rejection. J. Exp. Med. 159:57.
24. + T cell subsets. Transplantation 41:634.
25. Rosenberg, A. S., T. Mizouchi, S. O. Sharrow, and A. Singer. 1987. Phenotype specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165:1296.
26. Corley, R. B., and B. Kindred. 1977. In vivo responses of alloreactive lymphocytes stimulated in vitro: helper cell activity of MLR-primed lymphocytes. Scand. J. Immunol. 6:923.
27. Cobbold, S. P., G. Martin, and H. Waldman. 1990. The induction of skin graft tolerance in MHC mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8. Eur. J. Immunol. 20:2747.
28. Ichikawa, T., E. Nakayama, A. Uenaka, M. Monden, and T. Mori. 1987. Effector cells in allelic H-2 class I incompatible skin graft rejection. J. Exp. Med. 166:982.
29. + cells in mediating skin graft rejection against different amounts of transgenic H-2Kb antigen. J. Exp. Med. 173:261.
30. Wecker, H., M. J. Grusby, and H. Auchinloss, Jr. 1995. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice. Transplantation 59:1223.
31. Kruisbeek, A. M., M. L. Davis, L. A. Matis, and D. L. Longo. 1984. Self recognition specificity expressed by T cells from nude mice. J. Exp. Med. 160:839.
32. Mitchison, N. A., and C. O'Malley. 1987. Three-cell type clusters of T cells with antigen presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 17:1579.
33. Rosenberg, A. S., D. S. Finbloom, T. G. Maniero, P. H. Van der Meide, and A. Singer. 1990. Specific prolongation of MHC class II disparate skin allografts by administration of anti IFN-γ monoclonal antibody. J. Immunol. 144:4648.
34. Hall, B. M., S. E. Dorsch, and B. J Roser. 1977. Magnitude of memory to the major histocompatibility complex. Nature 268:532.
35. Gurley, K. E., B. M. Hall, and S. E. Dorsch. 1986. The factor of immunization in allograft rejection: carried by cytotoxic T cells not by helper T cells. Transplant. Proc. 18:307.
36. + cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 85:5205.
37. -/- mice is biased toward the helper phenotype. J. Immunol. 155:3227.
38. 2 microglobulin deficient mice. Eur. J. Immunol. 23:3115.
39. 2 microglobulin-deficient mice. Science 255:1576.
40. Nickerson, P., W. Steurer, J. Steiger, X. Zheng, A. W. Steele, and T. B. Strom. 1994. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6:757.
41. Geppert, T. D., and P. E. Lipsky. 1991. Immobilized anti-CD3-induced T cell growth: comparison of the frequency of responding cells with various subsets. Cell. Immunol. 133:206.
42. + T cells from young and old mice. J. Immunol. 150:3602.
43. Brett, J., H. Gerlach, P. Nawroth, S. Steinberg, G. Goodman, and D. Stern. 1989. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 169:1977.
44. Doody, D. P., K. S. Stenger, and H. J. Winn. 1994. Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts. J. Exp. Med. 179:1645.
45. Nawrot, P. P., and D. M. Stern. 1987. Endothelial cell procoagulant properties and the host response. Semin. Thromb. Hemost. 13:391.
46. Suttles, J., R. G. Miller, X. Tao, and R. D. Stout. 1994. T cells which do not express membrane TNFα function by cell-contact-dependent signaling of macrophage TNF-α production. Eur. J. Immunol. 24:1736.
47. Herbert, J., and B. Roser. 1988. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplant. Transplantation 46:1288.
48. Ichikawa, T., E. Nakayama, A. Uenaka, M. Monden, and T. Mori. 1987. Effector cells in allelic H-2 class I-incompatible skin graft rejection. J. Exp. Med. 166:982.
49. Macatonia, S. E., T. M. Doherty, S. C. Knight, and A. O'Gara. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and TFN-γ production. J. Immunol. 150:3755.
50. Swain, S. S. 1994. Generation of in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543.